NCT00086034View on ClinicalTrials.gov

Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

Not specified

Conditions
LymphomaNon-Hodgkin's Lymphoma
Interventions
DRUG

Motexafin gadolinium

Trial Locations (7)

21231

Baltimore

33136

Miami

53792

Madison

55905

Rochester

60611

Chicago

92121

San Diego

94305

Stanford

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY